NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025
Margaret von Mehren, John M. Kane, Samantha A. Armstrong, Tessa Balach, Andrew J. Bishop, Darya Buehler, Janai Carr-Ascher, Edwin Choy, Cara Cipriano, Mary Connolly, Amanda Dann, Elizabeth J. Davis, Sarah Dry, Vanessa Eulo, Kristen N. Ganjoo, Ricardo J. Gonzalez, Pedro A. Hermida De Viveiros, Ying J. Hitchcock, Edward Kim, Daniel Lefler, David Liebner, Martin McCarter, Sean V. McGarry, Nathan W. Mesko, Christian Meyer, Kambiz Motamedi, Sujana Movva, Alberto S. Pappo, Seth M. Pollack, Matthew Poppe, Richard F. Riedel, Steven Robinson, Scott M. Schuetze, Jason K. Sicklick, William W. Tseng, Mia C. Weiss, Melissa Zimel, Lisa E. Hang, Mary Anne Bergman, Zeenat Diwan
Abstract
The treatment landscape for soft tissue sarcomas (STS) is evolving constantly. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for STS specific to surgical management and systemic therapy recommendations for various subtypes.